期刊
IMMUNOLOGY
卷 126, 期 3, 页码 329-335出版社
WILEY
DOI: 10.1111/j.1365-2567.2008.03051.x
关键词
experimental autoimmune encephalomyelitis; interleukin-17; oestrogen; programmed death 1; regulatory T cells
类别
资金
- National Institutes of Health [NS45445, NS23221, NS49210]
- National Multiple Sclerosis Society [RG3405, PP1295]
- Nancy Davis Center without Walls
- Biomedical Laboratory R&D Service, Department of Veterans Affairs
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049210, R01NS023221, R01NS045445] Funding Source: NIH RePORTER
The mechanism by which oestrogens suppress experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, is only partially understood. We here demonstrate that treatment with 17 beta-oestradiol (E-2) in C57BL/6 mice boosted the expression of programmed death 1 (PD-1), a negative regulator of immune responses, in the CD4(+) FoxP3(+) regulatory T (Treg) cell compartment in a dose-dependent manner that correlated with the efficiency of EAE protection. Administration of E-2 at pregnancy levels but not lower concentrations also enhanced the frequency of Treg cells. Additionally, E-2 treatment drastically reduced the production of interleukin-17 (IL-17) in the periphery of immunized mice. However, E-2 treatment did not protect against EAE or suppress IL-17 production in PD-1 gene-deficient mice. Finally, E-2 failed to prevent Treg-deficient mice from developing spontaneous EAE. Taken together, our results suggest that E-2-induced protection against EAE is mediated by upregulation of PD-1 expression within the Treg-cell compartment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据